Genmark Diagnostics reported $19.4M in Gross Profit on Sales for its fourth fiscal quarter of 2020.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Gross Profit On Sales Change
Abbott ABT:US $ 6505M 1225M
Agilent A:US $ 852M 35M
Bruker BRKR:US $ 280.6M 1.9M
Danaher DHR:US $ 4359M 38M
Genmark Diagnostics GNMK:US $ 19.4M 2.86M
Hologic HOLX:US $ 701.6M 384.2M
Illumina ILMN:US $ 802M 38M
Laboratory Of America LH:US $ 1264.8M 334.2M
Luminex LMNX:US $ 66.46M 2.02M
Mesa Laboratories MLAB:US $ 22.21M 2.52M
Myriad Genetics MYGN:US $ 135.7M 12.9M
Nanostring Technologies NSTG:US $ 18.38M 2.39M
Orasure Technologies OSUR:US $ 30.67M 7.65M
Oxford Immunotec Global OXFD:US $ 14.86M 11.19M
Pacific Biosciences Of California PACB:US $ 13.75M 0.78M
Perkinelmer PKI:US $ 685.19M 99.95M
Quest Diagnostics DGX:US $ 1111M 114M
Quidel QDEL:US $ 106.19M 195.77M
Siemens SIE:GR 5.87B 633M
Thermo Fisher Scientific TMO:US $ 4688M 521M
Veracyte VCYT:US $ 37.63M 13.33M
Waters WAT:US $ 401.39M 47M